Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.
The formation of new blood vessels has become a major focus of mammary gland research stimulated by the therapeutic opportunities of controlling angiogenesis in breast cancer. Normal growth and involution of the mammary gland are profoundly affected by the expansion and regression of blood vessels, whereas dysregulation of angiogenesis is characteristic of breast cancer growth and metastasis. Prolactin stimulates the growth and differentiation of the mammary gland under normal conditions, but its role in breast cancer is controversial. Its action is complicated by the fact that prolactin itself is angiogenic, but proteases cleave prolactin to generate vasoinhibins, a family of peptides that act on endothelial cells to suppress angiogenesis and vasodilation and to promote apoptosis-mediated vascular regression. This review summarizes our current knowledge about the vascular effects of prolactin and the generation and action of vasoinhibins, and discusses their possible contribution to the regulation of blood vessels in the normal and malignant mammary gland.
Clapp
Carmen
C
Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM-Juriquilla, Querétaro, Qro, México 76230. clapp@servidor.unam.mx
Thebault
Stéphanie
S
Martínez de la Escalera
Gonzalo
G
D020533:Angiogenesis Inhibitors / Q000378:metabolism*; D000818:Animals; D001943:Breast Neoplasms / Q000098:blood supply / Q000378:metabolism; D006801:Humans; D008321:Mammary Glands, Animal / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology; D042361:Mammary Glands, Human / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology; D011388:Prolactin / Q000737:chemistry / Q000378:metabolism*; D014664:Vasodilation
D020533:Angiogenesis Inhibitors; D011388:Prolactin